The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
Authors:
- 1 January 2016
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 52, 92-101
Abstract
No abstract availableKeywords
Funding Information
- European Union's Seventh Framework Programme (261474)
- Hepatoblastoma Foundation
- Madeleine Schickedanz Children's Cancer Foundation
- Ministry of Education, Culture, Sports, Science of Japan
This publication has 21 references indexed in Scilit:
- Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposiumLaboratory Investigation, 2014
- Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLTPediatric Surgery International, 2010
- Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR StudyJournal of Clinical Oncology, 2010
- Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk HepatoblastomaNew England Journal of Medicine, 2009
- Amifostine does not prevent platinum‐induced hearing loss associated with the treatment of children with hepatoblastomaCancer, 2009
- Predictive power of pretreatment prognostic factors in children with hepatoblastoma: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2009
- The challenge of very rare tumours in childhood: The Italian TREP projectEuropean Journal of Cancer, 2007
- Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results From the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 StudyJournal of Clinical Oncology, 2005
- Pretreatment prognostic factors and treatment results in children with hepatoblastomaCancer, 2002
- Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology GroupJournal of Clinical Oncology, 2000